References
- Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189–199
- Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H, et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol 1994; 87: 746–754
- Greenberg P, Cox C, Le Beau M M, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–2088
- Vardiman J W, Harris N L, Brunning R D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292–2302
- Onida F, Kantarjian H M, Smith T L, Ball G, Keating M J, Estey E H, et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood 2002; 99: 840–899
- Onida F, Ball G, Kantarjian H M, Smith T L, Glassman A, Albitar M, et al. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia. Cancer 2002; 95: 1673–1684
- Kantarjian H M, Shtalrid M, Kurzrock R, Blick M, Dalton W T, LeMaistre A, et al. Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. Am J Med 1988; 85: 639–644
- Murphy S, Iland H, Rosenthal D, Laszlo J. Essential thrombocytopenia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 1982; 23: 177–182
- Berlin N I. Diagnosis and classification of the polycythemias. Semin Hematol 1975; 12: 339–351
- Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H, et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol 1994; 87: 746–754
- Barosi G. Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol 1999; 17: 2954–2970
- Weller P F, Bubley G J. The idiopathic hypereosinophilic syndrome. Blood 1994; 83: 2759–2779
- Arico M, Biondi A, Pui Ch -H. Juvenile Myelomonocytic Leukemia. Blood, 90: 479–488
- Thall P F, Estey E H. Graphical methods for evaluating covariates effects in the Cox model. Handbook of Statistics in Clinical Oncology, J Cowley. Marcel Dekker, New York, NY 2001; 411–432
- Lachin J M. Biostatistical Methods: The Assessment of Relative Risks. John Wiley & Sons, Inc., New York, NY 2000